Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Principal TechnologiesFRA:JO7 -12.50%9 12-1 Month Momentum % is 14.53% as of Sep. 06, 2026. GuruFocus rates FRA:JO7 with a GF Score™ of 9/100 and a GF Value™ of €0.04 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Principal Technologies ranks better than 57.9% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-06), Principal Technologies's 12-1 Month Momentum % is 14.53%.
The industry rank for Principal Technologies's 12-1 Month Momentum % or its related term are showing as below:
FRA:JO7's 12-1 Month Momentum % is ranked better than 57.9% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: -12.425
vs FRA:JO7: 14.53
Principal Technologies (FRA:JO7) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Principal Technologies 12-1 Month Momentum % Related Terms
FRA:JO7 vs VEEV, BTSG, TEM: 12-1 Month Momentum % Comparison
For the Health Information Services subindustry, Principal Technologies's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Principal Technologies 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Principal Technologies's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Principal Technologies's 12-1 Month Momentum % falls into.
Principal Technologies (FRA:JO7) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Principal Technologies (FRA:JO7) has a 12-1 Month Momentum % of 14.53% as of Sep. 06, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Principal Technologies and its competitors. According to the industry distribution chart, Principal Technologies ranks #277 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 42.1%.
Is Principal Technologies' 12-1 Month Momentum % too high?
Principal Technologies' current 12-1 Month Momentum % is 14.53%. Based on the distribution chart, Principal Technologies ranks #277 out of 658 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Principal Technologies has a GF Score™ of 9/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Principal Technologies' 12-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Principal Technologies ranks #277 out of 658 companies for 12-1 Month Momentum %. This puts Principal Technologies in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Principal Technologies and its competitors. Principal Technologies's current 12-1 Month Momentum % is 14.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Principal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Principal Technologies (FRA:JO7) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.04, compared to a current price of €0.19 — trading 381.3% above its estimated fair value. The current 12-1 Month Momentum % is 14.53%. Principal Technologies' overall GF Score™ is 9/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Principal Technologies (FRA:JO7), the current 12-1 Month Momentum % is 14.53% as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Principal Technologies (FRA:JO7) Overvalued in 2026?
Based on GuruFocus' analysis, Principal Technologies stock appears to be overvalued.
The current stock price of €0.19 is trading 381.3% above its estimated GF Value™ of €0.04.
GuruFocus considers Principal Technologies to be Significantly Overvalued.
Key valuation signals for FRA:JO7:
12-1 Month Momentum %: 14.53%
GF Value™: €0.04 vs. price of €0.19 (381.3% above fair value)
No single metric tells the full story. See the FRA:JO7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Principal Technologies Inc is in the research and development stage of building a portfolio of medical technology assets with a focus on distribution potential and intellectual property capable of enhancing medical treatment, cost efficiency, and optimization of the patient pathway. The company focuses on acquiring medical technology research and development assets or developing them jointly with industry leaders. Its current revenue-generating activities are attributable to E&E CRO Consulting GmbH, which provides clinical research advisory services. The company operates in one reportable operational segment, consisting of project management of clinical studies and research related to medical device technologies.
9GF Score
Get the complete analysis for FRA:JO7
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JO7 has been successfully added to your 
